PJ Ramtin

PJ has more than 20 years of experience in the biotechnology and pharmaceutical industries building and leading high-performing teams across commercial organizations and patient support functions.  She has worked in both start-up companies and global organizations with a focus on rare diseases. In her current role as Vice President of Commercial Operations at BridgeBio, PJ supports the development, and commercialization of breakthrough medicines for genetic diseases.

During her tenure with Genentech, Regeneron, InterMune, GlaxoSmithKline, and Bristol Myers Squibb, PJ supported the development and commercialization of approximately 20 medicines, diagnostics, and delivery devices across oncology, rare disease, and immunology therapy areas. She has a passion for mentoring women in healthcare and volunteering for patient communities.